Pharmacoeconomics and Outcomes Research Iberia-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 1, pp. 73-83

2009

  1. Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing crohn's disease

    Journal of Clinical Gastroenterology, Vol. 43, Núm. 10, pp. 950-956